Drug Trial Radar · NCT07473700
Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
Last checked: Nov 19, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
25
Planned (sponsor's estimate)
Start
Oct 30, 2026
Primary completion
Nov 21, 2027
Study completion Dec 11, 2027
Sponsor
- Lead sponsor
- Tectonic Operating Company, Inc.Industry
- Sponsor type
- Industry
- First posted
- Mar 16, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary purpose of this study is to assess the effect of TX000045 on pulmonary vascular resistance (PVR) in participants with pulmonary hypertension secondary to interstitial lung disease (PH-ILD) and to assess the safety and tolerability of TX000045 in participants with PH-ILD.
Conditions
- Hypertension, Pulmonary
- Lung Diseases, Interstitial
Interventions
TX000045Drug
Subcutaneous Injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Change from Baseline in PVR up to 16 WeeksTime frame: Baseline up to 16 weeks
- Number of Participants with Adverse Events (AEs), Adverse Events of Special Interest (AESIs) and Serious Adverse Events (SAEs)Time frame: Baseline up to 21 weeks
- Number of Participants with Clinically Significant Changes from Baseline in Safety Laboratory Assessments, 12-Lead Electrocardiogram (ECG) Assessments and Vital Sign AssessmentsTime frame: Baseline up to 21 weeks
Locations
16 sites in 6 countries. Site status is shown where the registry gives one.
Phoenix
Phoenix, Arizona · Recruiting
San Francisco
San Francisco, California · Recruiting
Idaho
Boise, Idaho · Not yet recruiting
Allen Park
Allen Park, Michigan · Recruiting
Krakow
Krakow, Poland · Not yet recruiting
Lublin
Lublin, Poland · Not yet recruiting
Wroclaw
Wroclaw, Poland · Recruiting
Bucharest
Bucharest, Romania · Recruiting
Belgrade
Belgrade, Serbia · Recruiting
Sremska Kamenica
Kamenitz, Serbia · Recruiting
Niš
Niš, Serbia · Recruiting
Gyeonggi-Do
Gyeonggi-do, South Korea · Recruiting
Seoul
Seoul, South Korea · Recruiting
Barcelona
Barcelona, Spain · Not yet recruiting
Madrid
Madrid, Spain · Recruiting
Santander
Santander, Spain · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.